Dr Reddys unveils Methylprednisolone Sodium Succinate for Injection in US
Methylprednisolone sodium succinate for Injection, USP is an anti-inflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient.;
Advertisement
Hyderabad: Pharma major, Dr. Reddy's Laboratories Ltd., has announced the launch of Methylprednisolone Sodium Succinate for Injection, USP indicated for various conditions including arthritis, blood disorders and severe allergic reactions, in the U.S. market.
The product is a generic equivalent of SOLU-MEDROL (methylprednisolone sodium succinate for injection, USP) and has been approved by the U.S. Food and Drug Administration (USFDA).
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.